跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOMENSA NASAL SPRAY SUSPENSION 50 MCG/ACTUATION - HSA Drug Approval Details
Approvals
/
HSA
/
MOMENSA NASAL SPRAY SUSPENSION 50 MCG/ACTUATION
Approved
THERAPEUTIC
MOMENSA NASAL SPRAY SUSPENSION 50 MCG/ACTUATION
Farmea - Angers
🇸🇬 Health Sciences Authority
Approval Date
Mar 16, 2018
Approval ID
15d6bb1d24917eca
Company
Farmea - Angers
Type
Therapeutic
Approval Details
Approval Id
15d6bb1d24917eca
Drug Name
MOMENSA NASAL SPRAY SUSPENSION 50 MCG/ACTUATION
Product Name
MOMENSA NASAL SPRAY SUSPENSION 50 MCG/ACTUATION
Approval Number
SIN15453P
Approval Date
2018-03-16
Registrant
LOTUS INTERNATIONAL PTE. LTD.
Licence Holder
LOTUS INTERNATIONAL PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SPRAY
Route Of Administration
NASAL
Atc Code
R01AD09
Atc Item Name
mometasone
Pharma Manufacturer Name
LOTUS INTERNATIONAL PTE. LTD.
Company Detail Path
/organization/lotus-international-pte-ltd
Active Ingredients
Mometasone Furoate Monohydrate 51.73 mcg/actuation eqv. Mometasone Furoate Anhydrous
50 μg/actuation
MOMETASONE FUROATE MONOHYDRATE 51.73 MCG/ACTUATION EQV. MOMETASONE FUROATE ANHYDROUS
50 MCG/ACTUATION
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 16, 2018
Approval ID
15d6bb1d24917eca
Type
Therapeutic
Back to HSA Approvals
